Н. Романов.Болезнь Альцгеймера (неопр.). Все о нейродегенеративных заболеваниях. Деменция.com (10 января 2014). Дата обращения: 31 июля 2015. Архивировано из оригинала 12 августа 2015 года.
Perneczky R., Pohl C., Sorg C., Hartmann J., Komossa K., Alexopoulos P., Wagenpfeil S., Kurz A. Complex activities of daily living in mild cognitive impairment: conceptual and diagnostic issues (англ.) // Age and Ageing[англ.] : journal. — 2006. — Vol. 35, no. 3. — P. 240—245. — doi:10.1093/ageing/afj054. — PMID16513677.
Arnáiz E., Almkvist O. Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease (англ.) // Acta Neurol. Scand., Suppl. : journal. — 2003. — Vol. 179. — P. 34—41. — doi:10.1034/j.1600-0404.107.s179.7.x. — PMID12603249.
Rapp M.A., Reischies F.M. Attention and executive control predict Alzheimer disease in late life: results from the Berlin Aging Study (BASE) (англ.) // American Journal of Geriatric Psychiatry : journal. — 2005. — Vol. 13, no. 2. — P. 134—141. — doi:10.1176/appi.ajgp.13.2.134. — PMID15703322.
Craig D., Mirakhur A., Hart D.J., McIlroy S.P., Passmore A.P. A cross-sectional study of neuropsychiatric symptoms in 435 patients with Alzheimer's disease (англ.) // American Journal of Geriatric Psychiatry : journal. — 2005. — Vol. 13, no. 6. — P. 460—468. — doi:10.1176/appi.ajgp.13.6.460. — PMID15956265.
Robert P.H., Berr C., Volteau M., Bertogliati C., Benoit M., Sarazin M., Legrain S., Dubois B. Apathy in patients with mild cognitive impairment and the risk of developing dementia of Alzheimer's disease: a one-year follow-up study (англ.) // Clinical Neurology and Neurosurgery[англ.] : journal. — 2006. — Vol. 108, no. 8. — P. 733—736. — doi:10.1016/j.clineuro.2006.02.003. — PMID16567037.
Petersen R.C. The current status of mild cognitive impairment—what do we tell our patients? (англ.) // Nat Clin Pract Neurol : journal. — 2007. — February (vol. 3, no. 2). — P. 60—1. — doi:10.1038/ncpneuro0402. — PMID17279076.
Jelicic M., Bonebakker A.E., Bonke B. Implicit memory performance of patients with Alzheimer's disease: a brief review (англ.) // International Psychogeriatrics : journal. — 1995. — Vol. 7, no. 3. — P. 385—392. — doi:10.1017/S1041610295002134. — PMID8821346.
Sartori G., Snitz B.E., Sorcinelli L., Daum I. Remote memory in advanced Alzheimer's disease (англ.) // Arch Clin Neuropsychol. — 2004. — September (vol. 19, no. 6). — P. 779—789. — doi:10.1016/j.acn.2003.09.007. — PMID15288331.
Neuropsychiatric symptoms: *Scarmeas N., Brandt J., Blacker D., et al. Disruptive behavior as a predictor in Alzheimer disease (англ.) // JAMA : journal. — 2007. — December (vol. 64, no. 12). — P. 1755—1761. — doi:10.1001/archneur.64.12.1755. — PMID18071039. *Tatsch M.F., Bottino C.M., Azevedo D., et al. Neuropsychiatric symptoms in Alzheimer disease and cognitively impaired, nondemented elderly from a community-based sample in Brazil: prevalence and relationship with dementia severity (англ.) // Am J Geriatr Psychiatry : journal. — 2006. — May (vol. 14, no. 5). — P. 438—445. — doi:10.1097/01.JGP.0000218218.47279.db. — PMID16670248. *Volicer L., Bass E.A., Luther S.L. Agitation and resistiveness to care are two separate behavioral syndromes of dementia (англ.) // J Am Med Dir Assoc : journal. — 2007. — October (vol. 8, no. 8). — P. 527—532. — doi:10.1016/j.jamda.2007.05.005. — PMID17931577.
Bär M., Kruse A., Re S. [Situations of emotional significance in residents suffering from dementia] (нем.) // Z Gerontol Geriatr. — 2003. — Dezember (Bd. 36, Nr. 6). — S. 454—462. — doi:10.1007/s00391-003-0191-0. — PMID14685735.
Games D., Adams D., Alessandrini R., et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein (англ.) // Nature : journal. — 1995. — February (vol. 373, no. 6514). — P. 523—527. — doi:10.1038/373523a0. — PMID7845465.
Holmes C., Boche D., Wilkinson D., et al. Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial (англ.) // The Lancet : journal. — Elsevier, 2008. — July (vol. 372, no. 9634). — P. 216—223. — doi:10.1016/S0140-6736(08)61075-2. — PMID18640458.
Musiek Erik S, Holtzman David M. Three dimensions of the amyloid hypothesis: time, space and 'wingmen' // Nature Neuroscience. — 2015. — Vol. 18. — P. 800—806. — ISSN1097-6256. — doi:10.1038/nn.4018. — PMID26007213.
Hashimoto M., Rockenstein E., Crews L., Masliah E. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases (англ.) // NeuroMolecular Medicine[англ.] : journal. — 2003. — Vol. 4, no. 1—2. — P. 21—36. — doi:10.1385/NMM:4:1-2:21. — PMID14528050.
Priller C., Bauer T., Mitteregger G., Krebs B., Kretzschmar H.A., Herms J. Synapse formation and function is modulated by the amyloid precursor protein (англ.) // Journal of Neuroscience[англ.] : journal. — 2006. — July (vol. 26, no. 27). — P. 7212—7221. — doi:10.1523/JNEUROSCI.1450-06.2006. — PMID16822978.
Van Broeck B., Van Broeckhoven C., Kumar-Singh S. Current insights into molecular mechanisms of Alzheimer disease and their implications for therapeutic approaches (англ.) // Neurodegener Dis : journal. — 2007. — Vol. 4, no. 5. — P. 349—365. — doi:10.1159/000105156. — PMID17622778.
Chen X., Yan S.D. Mitochondrial Abeta: a potential cause of metabolic dysfunction in Alzheimer's disease (англ.) // IUBMB Life : journal. — 2006. — December (vol. 58, no. 12). — P. 686—694. — doi:10.1080/15216540601047767. — PMID17424907.
Waring S.C., Rosenberg R.N. Genome-wide association studies in Alzheimer disease (англ.) // JAMA : journal. — 2008. — March (vol. 65, no. 3). — P. 329—334. — doi:10.1001/archneur.65.3.329. — PMID18332245.
Campion D., Dumanchin C., Hannequin D., et al. Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum (англ.) // American Journal of Human Genetics[англ.] : journal. — 1999. — September (vol. 65, no. 3). — P. 664—670. — doi:10.1086/302553. — PMID10441572. — PMC1377972.
Dubois B., Feldman H.H., Jacova C., et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria (англ.) // The Lancet : journal. — Elsevier, 2007. — August (vol. 6, no. 8). — P. 734—746. — doi:10.1016/S1474-4422(07)70178-3. — PMID17616482.
Waldemar G., Dubois B., Emre M., et al. Recommendations for the Diagnosis and Management of Alzheimer's Disease and Other Disorders Associated with Dementia: EFNS Guideline (англ.) // European Journal of Neurology[англ.] : journal. — 2007. — January (vol. 14, no. 1). — P. e1—26. — doi:10.1111/j.1468-1331.2006.01605.x. — PMID17222085.
Clarfield A.M. The decreasing prevalence of reversible dementias: an updated meta-analysis (англ.) // JAMA : journal. — 2003. — October (vol. 163, no. 18). — P. 2219—2229. — doi:10.1001/archinte.163.18.2219. — PMID14557220.
Potter G.G., Steffens D.C. Contribution of depression to cognitive impairment and dementia in older adults (англ.) // Neurologist : journal. — 2007. — May (vol. 13, no. 3). — P. 105—117. — doi:10.1097/01.nrl.0000252947.15389.a9. — PMID17495754.
Dougall N.J., Bruggink S., Ebmeier K.P. Systematic review of the diagnostic accuracy of 99mTc-HMPAO-SPECT in dementia (англ.) // Am J Geriatr Psychiatry : journal. — 2004. — Vol. 12, no. 6. — P. 554—570. — doi:10.1176/appi.ajgp.12.6.554. — PMID15545324.
PiB PET:
Kemppainen N.M., Aalto S., Karrasch M., et al. Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease (англ.) // Annals of Neurology[англ.] : journal. — 2008. — January (vol. 63, no. 1). — P. 112—118. — doi:10.1002/ana.21212. — PMID18023012.
Marksteiner J., Hinterhuber H., Humpel C. Cerebrospinal fluid biomarkers for diagnosis of Alzheimer's disease: beta-amyloid(1-42), tau, phospho-tau-181 and total protein (англ.) // Drugs Today : journal. — 2007. — June (vol. 43, no. 6). — P. 423—431. — doi:10.1358/dot.2007.43.6.1067341. — PMID17612711.
Scarmeas N., Stern Y., Mayeux R., Luchsinger J.A. Mediterranean diet, Alzheimer disease, and vascular mediation (англ.) // JAMA. — 2006. — Vol. 63, no. 12. — P. 1709—1717. — doi:10.1001/archneur.63.12.noc60109. — PMID17030648.
Curcumin in diet:
Garcia-Alloza M., Borrelli L.A., Rozkalne A., Hyman B.T., Bacskai B.J. Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model (англ.) // Journal of Neurochemistry[англ.] : journal. — 2007. — Vol. 102, no. 4. — P. 1095—1104. — doi:10.1111/j.1471-4159.2007.04613.x. — PMID17472706.
Patterson C., Feightner J.W., Garcia A., Hsiung G.Y., MacKnight C., Sadovnick A.D. Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease (англ.) // Canadian Medical Association Journal[англ.] : journal. — 2008. — February (vol. 178, no. 5). — P. 548—556. — doi:10.1503/cmaj.070796. — PMID18299540. — PMC2244657.
Davanipour Z., Tseng C.C., Lee P.J., Sobel E. A case-control study of occupational magnetic field exposure and Alzheimer's disease: results from the California Alzheimer's Disease Diagnosis and Treatment Centers (англ.) // BMC Neurol : journal. — 2007. — Vol. 7. — P. 13. — doi:10.1186/1471-2377-7-13. — PMID17559686. — PMC1906833.
Bennett D.A., Schneider J.A., Tang Y., Arnold S.E., Wilson R.S. The effect of social networks on the relation between Alzheimer's disease pathology and level of cognitive function in old people: a longitudinal cohort study (англ.) // The Lancet : journal. — Elsevier, 2006. — Vol. 5, no. 5. — P. 406—412. — doi:10.1016/S1474-4422(06)70417-3. — PMID16632311.
Ballard C., Hanney M.L., Theodoulou M., Douglas S., McShane R., Kossakowski K., Gill R., Juszczak E., Yu L-M, Jacoby R. The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial (англ.) // The Lancet : journal. — Elsevier, 2009. — 9 January. — doi:10.1016/S1474-4422(08)70295-3. — PMID19138567.
Knopman, D. S. Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019 : [англ.] / D. S. Knopman, D. T. Jones, M. D. Greicius // Alzheimer's & Dementia : журн. — 2021. — Vol. 17, no. 4. — P. 696–701. — doi:10.1002/alz.12213. — PMID33135381.
Mullard, A. Landmark Alzheimer’s drug approval confounds research community : Many scientists say there is not enough evidence that Biogen’s aducanumab is an effective therapy for the disease. : [англ.] // Nature : журн. — 2021. — 8 June. — doi:10.1038/d41586-021-01546-2.
Thompson C.A., Spilsbury K., Hall J., Birks Y., Barnes C., Adamson J. Systematic review of information and support interventions for caregivers of people with dementia (англ.) // BMC Geriatr : journal. — 2007. — Vol. 7. — P. 18. — doi:10.1186/1471-2318-7-18. — PMID17662119. — PMC1951962.
Ganguli M., Dodge H.H., Shen C., Pandav R.S., DeKosky S.T. Alzheimer disease and mortality: a 15-year epidemiological study (англ.) // JAMA : journal. — 2005. — May (vol. 62, no. 5). — P. 779—784. — doi:10.1001/archneur.62.5.779. — PMID15883266.
Allegri R.F., Butman J., Arizaga R.L., et al. Economic impact of dementia in developing countries: an evaluation of costs of Alzheimer-type dementia in Argentina (англ.) // Int Psychogeriatr : journal. — 2007. — August (vol. 19, no. 4). — P. 705—718. — doi:10.1017/S1041610206003784. — PMID16870037.
Wimo A., Jonsson L., Winblad B. An estimate of the worldwide prevalence and direct costs of dementia in 2003 (англ.) // Dement Geriatr Cogn Disord : journal. — 2006. — Vol. 21, no. 3. — P. 175—181. — doi:10.1159/000090733. — PMID16401889.
Garrard P., Maloney L.M., Hodges J.R., Patterson K. The effects of very early Alzheimer's disease on the characteristics of writing by a renowned author (англ.) // Brain[англ.] : journal. — Oxford University Press, 2005. — February (vol. 128, no. Pt 2). — P. 250—260. — doi:10.1093/brain/awh341. — PMID15574466.
Vaccination:
Hawkes C.A., McLaurin J. Immunotherapy as treatment for Alzheimer's disease (англ.) // Expert Rev Neurother. — 2007. — November (vol. 7, no. 11). — P. 1535—1548. — doi:10.1586/14737175.7.11.1535. — PMID17997702.
Kim, H. Y., Kim, H. V., Jo, S., Lee, C. J., Choi, S. Y., Kim, D. J., & Kim, Y. (2015). EPPS rescues hippocampus-dependent cognitive deficits in APP/PS1 mice by disaggregation of amyloid-[beta] oligomers and plaques. Nature communications, 6, Article number: 8997 doi:10.1038/ncomms9997
Marschallinger, J., Schäffner, I., Klein, B., Gelfert, R., Rivera, F. J., Illes, S., … & Coras, R. (2015). Structural and functional rejuvenation of the aged brain by an approved anti-asthmatic drug. Nature communications, 6, Article number: 8466 doi:10.1038/ncomms9466
Raha, S., Ghosh, A., Dutta, D., Patel, D. R., & Pahan, K. (2021). Activation of PPARα enhances astroglial uptake and degradation of β-amyloid. Science Signaling, 14(706), eabg4747. PMID34699252doi:10.1126/scisignal.abg4747
Harrington Charles, Rickard Janet E., Horsley David, et al. Methylthioninium chloride (MTC) acts as a Tau aggregation inhibitor (TAI) in a cellular model and reverses Tau pathology in transgenic mouse models of Alzheimer's disease (англ.) // Alzheimer's & Dementia : journal. — Alzheimer’s Association, 2008. — July (vol. 4). — P. T120—T121. — doi:10.1016/j.jalz.2008.05.259.
Doody R.S., Gavrilova S.I., Sano M., et al. Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study (англ.) // The Lancet : journal. — Elsevier, 2008. — July (vol. 372, no. 9634). — P. 207—215. — doi:10.1016/S0140-6736(08)61074-0. — PMID18640457.
Choi Se Hoon, Kim Young Hye, Hebisch Matthias, Sliwinski Christopher, Lee Seungkyu, d’Avanzo Carla, Chen Hechao, Hooli Basavaraj, Asselin Caroline, Muffat Julien, Klee Justin B., Zhang Can, Wainger Brian J., Peitz Michael, Kovacs Dora M., Woolf Clifford J., Wagner Steven L., Tanzi Rudolph E., Kim Doo Yeon.A three-dimensional human neural cell culture model of Alzheimer’s disease (англ.) // Nature. — 2014. — Vol. 515. — P. 274—278. — ISSN0028-0836. — doi:10.1038/nature13800. Архивировано 29 мая 2016 года.
Aducanumab : Alzheimer’s Disease : Combined FDA and Biogen Briefing Information for the November 6, 2020 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee : [англ.] : [арх. 7 ноября 2020] / Peripheral and Central Nervous System (PCNS) Drugs Advisory Committee; FDA. — 2020. — 6 November. — 343 p. — NDA/BLA# 761178.
Berchtold N.C., Cotman C.W. Evolution in the conceptualization of dementia and Alzheimer's disease: Greco-Roman period to the 1960s (англ.) // Neurobiology of Aging : journal. — 1998. — Vol. 19, no. 3. — P. 173—189. — PMID9661992.
Brookmeyer R., Gray S., Kawas C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset (англ.) // American Journal of Public Health[англ.] : journal. — 1998. — September (vol. 88, no. 9). — P. 1337—1342. — PMID9736873. — PMC1509089.
Tabert M.H., Liu X., Doty R.L., Serby M., Zamora D., Pelton G.H., Marder K., Albers M.W., Stern Y., Devanand D.P. A 10-item smell identification scale related to risk for Alzheimer's disease (англ.) // Annals of Neurology[англ.] : journal. — 2005. — Vol. 58, no. 1. — P. 155—160. — ISSN0364-5134. — doi:10.1002/ana.20533. — PMID15984022.
Mölsä P.K., Marttila R.J., Rinne U.K. Survival and cause of death in Alzheimer's disease and multi-infarct dementia (англ.) // Acta Neurologica Scandinavica[англ.] : journal. — 1986. — August (vol. 74, no. 2). — P. 103—107. — PMID3776457.
Mölsä P.K., Marttila R.J., Rinne U.K. Long-term survival and predictors of mortality in Alzheimer's disease and multi-infarct dementia (англ.) // Acta Neurologica Scandinavica[англ.] : journal. — 1995. — March (vol. 91, no. 3). — P. 159—164. — PMID7793228.
Tiraboschi P., Hansen L.A., Thal L.J., Corey-Bloom J. The importance of neuritic plaques and tangles to the development and evolution of AD (англ.) // Neurology : journal. — Wolters Kluwer[англ.], 2004. — June (vol. 62, no. 11). — P. 1984—1989. — PMID15184601.
Bonin-Guillaume S., Zekry D., Giacobini E., Gold G., Michel J.P. Impact économique de la démence (English: The economical impact of dementia) (фр.) // La Presse médicale[англ.]. — 2005. — Janvier (vol. 34, no 1). — P. 35—41. — ISSN0755-4982. — PMID15685097.
Meek P.D., McKeithan K., Schumock G.T. Economic considerations in Alzheimer's disease (англ.) // Pharmacotherapy. — 1998. — Vol. 18, no. 2 Pt 2. — P. 68—73; discussion 79—82. — PMID9543467.
Amaducci L.A., Rocca W.A., Schoenberg B.S. Origin of the distinction between Alzheimer's disease and senile dementia: how history can clarify nosology (англ.) // Neurology : journal. — Wolters Kluwer[англ.], 1986. — November (vol. 36, no. 11). — P. 1497—1499. — PMID3531918.
Di Carlo A., Baldereschi M., Amaducci L., et al. Incidence of dementia, Alzheimer's disease, and vascular dementia in Italy. The ILSA Study (англ.) // Journal of the American Geriatrics Society[англ.] : journal. — 2002. — January (vol. 50, no. 1). — P. 41—8. — PMID12028245.
Andersen K., Launer L.J., Dewey M.E., et al. Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group (англ.) // Neurology : journal. — Wolters Kluwer[англ.], 1999. — December (vol. 53, no. 9). — P. 1992—1997. — PMID10599770.
2000 U.S. estimates:
Hebert L.E., Scherr P.A., Bienias J.L., Bennett D.A., Evans D.A. Alzheimer disease in the US population: prevalence estimates using the 2000 census (англ.) // JAMA : journal. — 2003. — August (vol. 60, no. 8). — P. 1119—1122. — doi:10.1001/archneur.60.8.1119. — PMID12925369.
Preclinical: *Linn R.T., Wolf P.A., Bachman D.L., et al. The 'preclinical phase' of probable Alzheimer's disease. A 13-year prospective study of the Framingham cohort (англ.) // JAMA : journal. — 1995. — May (vol. 52, no. 5). — P. 485—490. — PMID7733843.
Saxton J., Lopez O.L., Ratcliff G., et al. Preclinical Alzheimer disease: neuropsychological test performance 1.5 to 8 years prior to onset (англ.) // Neurology : journal. — Wolters Kluwer[англ.], 2004. — December (vol. 63, no. 12). — P. 2341—2347. — PMID15623697.
Perneczky R., Pohl C., Sorg C., Hartmann J., Komossa K., Alexopoulos P., Wagenpfeil S., Kurz A. Complex activities of daily living in mild cognitive impairment: conceptual and diagnostic issues (англ.) // Age and Ageing[англ.] : journal. — 2006. — Vol. 35, no. 3. — P. 240—245. — doi:10.1093/ageing/afj054. — PMID16513677.
Arnáiz E., Almkvist O. Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease (англ.) // Acta Neurol. Scand., Suppl. : journal. — 2003. — Vol. 179. — P. 34—41. — doi:10.1034/j.1600-0404.107.s179.7.x. — PMID12603249.
Rapp M.A., Reischies F.M. Attention and executive control predict Alzheimer disease in late life: results from the Berlin Aging Study (BASE) (англ.) // American Journal of Geriatric Psychiatry : journal. — 2005. — Vol. 13, no. 2. — P. 134—141. — doi:10.1176/appi.ajgp.13.2.134. — PMID15703322.
Spaan P.E., Raaijmakers J.G., Jonker C. Alzheimer's disease versus normal ageing: a review of the efficiency of clinical and experimental memory measures (англ.) // Journal of Clinical Experimental Neuropsychology : journal. — 2003. — Vol. 25, no. 2. — P. 216—233. — PMID12754679.
Craig D., Mirakhur A., Hart D.J., McIlroy S.P., Passmore A.P. A cross-sectional study of neuropsychiatric symptoms in 435 patients with Alzheimer's disease (англ.) // American Journal of Geriatric Psychiatry : journal. — 2005. — Vol. 13, no. 6. — P. 460—468. — doi:10.1176/appi.ajgp.13.6.460. — PMID15956265.
Robert P.H., Berr C., Volteau M., Bertogliati C., Benoit M., Sarazin M., Legrain S., Dubois B. Apathy in patients with mild cognitive impairment and the risk of developing dementia of Alzheimer's disease: a one-year follow-up study (англ.) // Clinical Neurology and Neurosurgery[англ.] : journal. — 2006. — Vol. 108, no. 8. — P. 733—736. — doi:10.1016/j.clineuro.2006.02.003. — PMID16567037.
Petersen R.C. The current status of mild cognitive impairment—what do we tell our patients? (англ.) // Nat Clin Pract Neurol : journal. — 2007. — February (vol. 3, no. 2). — P. 60—1. — doi:10.1038/ncpneuro0402. — PMID17279076.
Becker J.T., Overman A.A. [The semantic memory deficit in Alzheimer's disease] (Spanish; Castilian) // Revue neurologique[англ.]. — 2002. — Т. 35, № 8. — С. 777—783. — PMID12402233.
Hodges J.R., Patterson K. Is semantic memory consistently impaired early in the course of Alzheimer's disease? Neuroanatomical and diagnostic implications (англ.) // Neuropsychologia[англ.] : journal. — 1995. — April (vol. 33, no. 4). — P. 441—459. — PMID7617154.
Galasko D., Schmitt F., Thomas R., Jin S., Bennett D. Detailed assessment of activities of daily living in moderate to severe Alzheimer's disease (англ.) // Journal of the International Neuropsychology Society : journal. — 2005. — Vol. 11, no. 4. — P. 446—453. — PMID16209425.
Neuropsychiatric symptoms: *Scarmeas N., Brandt J., Blacker D., et al. Disruptive behavior as a predictor in Alzheimer disease (англ.) // JAMA : journal. — 2007. — December (vol. 64, no. 12). — P. 1755—1761. — doi:10.1001/archneur.64.12.1755. — PMID18071039. *Tatsch M.F., Bottino C.M., Azevedo D., et al. Neuropsychiatric symptoms in Alzheimer disease and cognitively impaired, nondemented elderly from a community-based sample in Brazil: prevalence and relationship with dementia severity (англ.) // Am J Geriatr Psychiatry : journal. — 2006. — May (vol. 14, no. 5). — P. 438—445. — doi:10.1097/01.JGP.0000218218.47279.db. — PMID16670248. *Volicer L., Bass E.A., Luther S.L. Agitation and resistiveness to care are two separate behavioral syndromes of dementia (англ.) // J Am Med Dir Assoc : journal. — 2007. — October (vol. 8, no. 8). — P. 527—532. — doi:10.1016/j.jamda.2007.05.005. — PMID17931577.
Honig L.S., Mayeux R. Natural history of Alzheimer's disease (англ.) // Aging (Milano). — 2001. — June (vol. 13, no. 3). — P. 171—182. — PMID11442300.
Gold D.P., Reis M.F., Markiewicz D., Andres D. When home caregiving ends: a longitudinal study of outcomes for caregivers of relatives with dementia (англ.) // Journal of the American Geriatrics Society[англ.] : journal. — 1995. — January (vol. 43, no. 1). — P. 10—6. — PMID7806732.
Bär M., Kruse A., Re S. [Situations of emotional significance in residents suffering from dementia] (нем.) // Z Gerontol Geriatr. — 2003. — Dezember (Bd. 36, Nr. 6). — S. 454—462. — doi:10.1007/s00391-003-0191-0. — PMID14685735.
Souren L.E., Franssen E.H., Reisberg B. Contractures and loss of function in patients with Alzheimer's disease (англ.) // Journal of the American Geriatrics Society[англ.] : journal. — 1995. — June (vol. 43, no. 6). — P. 650—655. — PMID7775724.
Berkhout A.M., Cools H.J., van Houwelingen H.C. The relationship between difficulties in feeding oneself and loss of weight in nursing-home patients with dementia (англ.) // Age and Ageing[англ.] : journal. — 1998. — September (vol. 27, no. 5). — P. 637—641. — PMID12675103.
Wada H., Nakajoh K., Satoh-Nakagawa T., et al. Risk factors of aspiration pneumonia in Alzheimer's disease patients (англ.) // Gerontology : journal. — 2001. — Vol. 47, no. 5. — P. 271—276. — PMID11490146.
Hardy J., Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer's disease (англ.) // Trends[англ.] : journal. — 1991. — October (vol. 12, no. 10). — P. 383—388. — PMID1763432.
Mudher A., Lovestone S. Alzheimer's disease-do tauists and baptists finally shake hands? (англ.) // Trends[англ.] : journal. — 2002. — January (vol. 25, no. 1). — P. 22—26. — PMID11801334.
Polvikoski T., Sulkava R., Haltia M., et al. Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein (англ.) // The New England Journal of Medicine : journal. — 1995. — November (vol. 333, no. 19). — P. 1242—1247. — PMID7566000.
Transgenic mice:
Games D., Adams D., Alessandrini R., et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein (англ.) // Nature : journal. — 1995. — February (vol. 373, no. 6514). — P. 523—527. — doi:10.1038/373523a0. — PMID7845465.
Holmes C., Boche D., Wilkinson D., et al. Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial (англ.) // The Lancet : journal. — Elsevier, 2008. — July (vol. 372, no. 9634). — P. 216—223. — doi:10.1016/S0140-6736(08)61075-2. — PMID18640458.
Schmitz C., Rutten B.P., Pielen A., et al. Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease (англ.) // The American Journal of Pathology[англ.] : journal. — 2004. — April (vol. 164, no. 4). — P. 1495—1502. — PMID15039236. — PMC1615337.
Musiek Erik S, Holtzman David M. Three dimensions of the amyloid hypothesis: time, space and 'wingmen' // Nature Neuroscience. — 2015. — Vol. 18. — P. 800—806. — ISSN1097-6256. — doi:10.1038/nn.4018. — PMID26007213.
Goedert M., Spillantini M.G., Crowther R.A. Tau proteins and neurofibrillary degeneration (англ.) // Brain Pathology[англ.]. — 1991. — July (vol. 1, no. 4). — P. 279—286. — PMID1669718.
Bouras C., Hof P.R., Giannakopoulos P., Michel J.P., Morrison J.H. Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a one-year autopsy population from a geriatric hospital (англ.) // Cerebral Cortex[англ.] : journal. — 1994. — Vol. 4, no. 2. — P. 138—150. — PMID8038565.
Hashimoto M., Rockenstein E., Crews L., Masliah E. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases (англ.) // NeuroMolecular Medicine[англ.] : journal. — 2003. — Vol. 4, no. 1—2. — P. 21—36. — doi:10.1385/NMM:4:1-2:21. — PMID14528050.
Priller C., Bauer T., Mitteregger G., Krebs B., Kretzschmar H.A., Herms J. Synapse formation and function is modulated by the amyloid precursor protein (англ.) // Journal of Neuroscience[англ.] : journal. — 2006. — July (vol. 26, no. 27). — P. 7212—7221. — doi:10.1523/JNEUROSCI.1450-06.2006. — PMID16822978.
Turner P.R., O'Connor K., Tate W.P., Abraham W.C. Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory (англ.) // Progress in Neurobiology : journal. — 2003. — May (vol. 70, no. 1). — P. 1—32. — PMID12927332.
Van Broeck B., Van Broeckhoven C., Kumar-Singh S. Current insights into molecular mechanisms of Alzheimer disease and their implications for therapeutic approaches (англ.) // Neurodegener Dis : journal. — 2007. — Vol. 4, no. 5. — P. 349—365. — doi:10.1159/000105156. — PMID17622778.
Yankner B.A., Duffy L.K., Kirschner D.A. Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides (англ.) // Science (journal) : journal. — 1990. — October (vol. 250, no. 4978). — P. 279—282. — PMID2218531.
Chen X., Yan S.D. Mitochondrial Abeta: a potential cause of metabolic dysfunction in Alzheimer's disease (англ.) // IUBMB Life : journal. — 2006. — December (vol. 58, no. 12). — P. 686—694. — doi:10.1080/15216540601047767. — PMID17424907.
Campion D., Dumanchin C., Hannequin D., et al. Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum (англ.) // American Journal of Human Genetics[англ.] : journal. — 1999. — September (vol. 65, no. 3). — P. 664—670. — doi:10.1086/302553. — PMID10441572. — PMC1377972.
Selkoe D.J. Translating cell biology into therapeutic advances in Alzheimer's disease (англ.) // Nature : journal. — 1999. — June (vol. 399, no. 6738 Suppl). — P. A23—31. — PMID10392577.
Seripa D., Matera M.G., Franceschi M., et al. The RELN locus in Alzheimer's disease (англ.) // J Alzheimers Dis.. — 2008. — July (vol. 14, no. 3). — P. 335—344. — PMID18599960.
Mendez M.F. The accurate diagnosis of early-onset dementia (англ.) // International Journal of Psychiatry Medicine. — 2006. — Vol. 36, no. 4. — P. 401—412. — PMID17407994.
McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease (англ.) // Neurology : journal. — Wolters Kluwer[англ.], 1984. — July (vol. 34, no. 7). — P. 939—944. — PMID6610841.
Dubois B., Feldman H.H., Jacova C., et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria (англ.) // The Lancet : journal. — Elsevier, 2007. — August (vol. 6, no. 8). — P. 734—746. — doi:10.1016/S1474-4422(07)70178-3. — PMID17616482.
Blacker D., Albert M.S., Bassett S.S., Go R.C., Harrell L.E., Folstein M.F. Reliability and validity of NINCDS-ADRDA criteria for Alzheimer's disease. The National Institute of Mental Health Genetics Initiative (англ.) // JAMA : journal. — 1994. — December (vol. 51, no. 12). — P. 1198—1204. — PMID7986174.
Ito N. [Clinical aspects of dementia] (яп.) // Hokkaido Igaku Zasshi. — 1996. — 5月 (第71巻, 第3数). — 第315—320 頁. — PMID8752526.
Pasquier F. Early diagnosis of dementia: neuropsychology (англ.) // Journal of Neurology[англ.]. — 1999. — January (vol. 246, no. 1). — P. 6—15. — PMID9987708.
Waldemar G., Dubois B., Emre M., et al. Recommendations for the Diagnosis and Management of Alzheimer's Disease and Other Disorders Associated with Dementia: EFNS Guideline (англ.) // European Journal of Neurology[англ.] : journal. — 2007. — January (vol. 14, no. 1). — P. e1—26. — doi:10.1111/j.1468-1331.2006.01605.x. — PMID17222085.
Harvey P.D., Moriarty P.J., Kleinman L., et al. The validation of a caregiver assessment of dementia: the Dementia Severity Scale (англ.) // Alzheimer Disease and Associated Disorders[англ.] : journal. — 2005. — Vol. 19, no. 4. — P. 186—194. — PMID16327345.
Antoine C., Antoine P., Guermonprez P., Frigard B. [Awareness of deficits and anosognosia in Alzheimer's disease.] (фр.) // Encephale. — 2004. — Vol. 30, no 6. — P. 570—577. — PMID15738860.
Cruz V.T., Pais J., Teixeira A., Nunes B. [The initial symptoms of Alzheimer disease: caregiver perception] (порт.) // Acta Med Port. — 2004. — Vol. 17, num. 6. — P. 435—444. — PMID16197855.
Clarfield A.M. The decreasing prevalence of reversible dementias: an updated meta-analysis (англ.) // JAMA : journal. — 2003. — October (vol. 163, no. 18). — P. 2219—2229. — doi:10.1001/archinte.163.18.2219. — PMID14557220.
Geldmacher D.S., Whitehouse P.J. Differential diagnosis of Alzheimer's disease (англ.) // Neurology. — Wolters Kluwer[англ.], 1997. — May (vol. 48, no. 5 Suppl 6). — P. S2—9. — PMID9153154.
Potter G.G., Steffens D.C. Contribution of depression to cognitive impairment and dementia in older adults (англ.) // Neurologist : journal. — 2007. — May (vol. 13, no. 3). — P. 105—117. — doi:10.1097/01.nrl.0000252947.15389.a9. — PMID17495754.
Dougall N.J., Bruggink S., Ebmeier K.P. Systematic review of the diagnostic accuracy of 99mTc-HMPAO-SPECT in dementia (англ.) // Am J Geriatr Psychiatry : journal. — 2004. — Vol. 12, no. 6. — P. 554—570. — doi:10.1176/appi.ajgp.12.6.554. — PMID15545324.
PiB PET:
Kemppainen N.M., Aalto S., Karrasch M., et al. Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease (англ.) // Annals of Neurology[англ.] : journal. — 2008. — January (vol. 63, no. 1). — P. 112—118. — doi:10.1002/ana.21212. — PMID18023012.
Marksteiner J., Hinterhuber H., Humpel C. Cerebrospinal fluid biomarkers for diagnosis of Alzheimer's disease: beta-amyloid(1-42), tau, phospho-tau-181 and total protein (англ.) // Drugs Today : journal. — 2007. — June (vol. 43, no. 6). — P. 423—431. — doi:10.1358/dot.2007.43.6.1067341. — PMID17612711.
Patterson C., Feightner J.W., Garcia A., Hsiung G.Y., MacKnight C., Sadovnick A.D. Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease (англ.) // Canadian Medical Association Journal[англ.] : journal. — 2008. — February (vol. 178, no. 5). — P. 548—556. — doi:10.1503/cmaj.070796. — PMID18299540. — PMC2244657.
Reiss A.B., Wirkowski E. Role of HMG-CoA reductase inhibitors in neurological disorders : progress to date (англ.) // Drugs[англ.] : journal. — Adis International, 2007. — Vol. 67, no. 15. — P. 2111—2120. — PMID17927279.
Davanipour Z., Tseng C.C., Lee P.J., Sobel E. A case-control study of occupational magnetic field exposure and Alzheimer's disease: results from the California Alzheimer's Disease Diagnosis and Treatment Centers (англ.) // BMC Neurol : journal. — 2007. — Vol. 7. — P. 13. — doi:10.1186/1471-2377-7-13. — PMID17559686. — PMC1906833.
Shcherbatykh I., Carpenter D.O. The role of metals in the etiology of Alzheimer's disease (англ.) // Journal of Alzheimer's Disease[англ.] : journal. — 2007. — May (vol. 11, no. 2). — P. 191—205. — PMID17522444.
Rondeau V., Commenges D., Jacqmin-Gadda H., Dartigues J.F. Relation between aluminum concentrations in drinking water and Alzheimer's disease: an 8-year follow-up study (англ.) // American Journal of Epidemiology : journal. — 2000. — July (vol. 152, no. 1). — P. 59—66. — PMID10901330. — PMC2215380.
Kukull W.A., Larson E.B., Bowen J.D., et al. Solvent exposure as a risk factor for Alzheimer's disease: a case-control study (англ.) // American Journal of Epidemiology : journal. — 1995. — June (vol. 141, no. 11). — P. 1059—1071. — PMID7771442.
Rondeau V. A review of epidemiologic studies on aluminum and silica in relation to Alzheimer's disease and associated disorders (англ.) // Rev Environ Health : journal. — 2002. — Vol. 17, no. 2. — P. 107—121. — PMID12222737.
Martyn C.N., Coggon D.N., Inskip H., Lacey R.F., Young W.F. Aluminum concentrations in drinking water and risk of Alzheimer's disease (англ.) // Epidemiology : journal. — 1997. — May (vol. 8, no. 3). — P. 281—286. — PMID9115023.
Graves A.B., Rosner D., Echeverria D., Mortimer J.A., Larson E.B. Occupational exposures to solvents and aluminium and estimated risk of Alzheimer's disease (англ.) // Occupational and Environmental Medicine[англ.] : journal. — 1998. — September (vol. 55, no. 9). — P. 627—633. — PMID9861186. — PMC1757634.
Bennett D.A., Schneider J.A., Tang Y., Arnold S.E., Wilson R.S. The effect of social networks on the relation between Alzheimer's disease pathology and level of cognitive function in old people: a longitudinal cohort study (англ.) // The Lancet : journal. — Elsevier, 2006. — Vol. 5, no. 5. — P. 406—412. — doi:10.1016/S1474-4422(06)70417-3. — PMID16632311.
Stahl S.M. The new cholinesterase inhibitors for Alzheimer's disease, Part 2: illustrating their mechanisms of action (англ.) // The Journal of Clinical Psychiatry[англ.] : journal. — 2000. — Vol. 61, no. 11. — P. 813—814. — PMID11105732.
Tacrine (By mouth) (неопр.). National Institutes of Health, USA. Дата обращения: 5 июля 2015.
Raina P., Santaguida P., Ismaila A., et al. Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline (англ.) // Annals of Internal Medicine[англ.] : journal. — 2008. — Vol. 148, no. 5. — P. 379—397. — PMID18316756.
Ballard C., Hanney M.L., Theodoulou M., Douglas S., McShane R., Kossakowski K., Gill R., Juszczak E., Yu L-M, Jacoby R. The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial (англ.) // The Lancet : journal. — Elsevier, 2009. — 9 January. — doi:10.1016/S1474-4422(08)70295-3. — PMID19138567.
Knopman, D. S. Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019 : [англ.] / D. S. Knopman, D. T. Jones, M. D. Greicius // Alzheimer's & Dementia : журн. — 2021. — Vol. 17, no. 4. — P. 696–701. — doi:10.1002/alz.12213. — PMID33135381.
Bottino C.M., Carvalho I.A., Alvarez A.M., et al. Cognitive rehabilitation combined with drug treatment in Alzheimer's disease patients: a pilot study (англ.) // Clinical Rehabilitation[англ.] : journal. — 2005. — Vol. 19, no. 8. — P. 861—869. — doi:10.1191/0269215505cr911oa. — PMID16323385.
Doody R.S., Stevens J.C., Beck C., et al. Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology (англ.) // Neurology : journal. — Wolters Kluwer[англ.], 2001. — Vol. 56, no. 9. — P. 1154—1166. — PMID11342679.
Camberg L., Woods P., Ooi W.L., et al. Evaluation of Simulated Presence: a personalised approach to enhance well-being in persons with Alzheimer's disease (англ.) // Journal of the American Geriatrics Society[англ.] : journal. — 1999. — Vol. 47, no. 4. — P. 446—452. — PMID10203120.
Thompson C.A., Spilsbury K., Hall J., Birks Y., Barnes C., Adamson J. Systematic review of information and support interventions for caregivers of people with dementia (англ.) // BMC Geriatr : journal. — 2007. — Vol. 7. — P. 18. — doi:10.1186/1471-2318-7-18. — PMID17662119. — PMC1951962.
Head B. Palliative care for persons with dementia (англ.) // Home Healthc Nurse. — 2003. — January (vol. 21, no. 1). — P. 53—60; quiz 61. — PMID12544465.
Bowen J.D., Malter A.D., Sheppard L., et al. Predictors of mortality in patients diagnosed with probable Alzheimer's disease (англ.) // Neurology : journal. — Wolters Kluwer[англ.], 1996. — August (vol. 47, no. 2). — P. 433—439. — PMID8757016.
Dodge H.H., Shen C., Pandav R., DeKosky S.T., Ganguli M. Functional transitions and active life expectancy associated with Alzheimer disease (англ.) // JAMA : journal. — 2003. — February (vol. 60, no. 2). — P. 253—259. — PMID12580712.
Larson E.B., Shadlen M.F., Wang L., et al. Survival after initial diagnosis of Alzheimer disease (англ.) // Annals of Internal Medicine[англ.] : journal. — 2004. — April (vol. 140, no. 7). — P. 501—509. — PMID15068977.
Jagger C., Clarke M., Stone A. Predictors of survival with Alzheimer's disease: a community-based study (англ.) // Psychological Medicine[англ.] : journal. — 1995. — January (vol. 25, no. 1). — P. 171—177. — PMID7792352.
Ganguli M., Dodge H.H., Shen C., Pandav R.S., DeKosky S.T. Alzheimer disease and mortality: a 15-year epidemiological study (англ.) // JAMA : journal. — 2005. — May (vol. 62, no. 5). — P. 779—784. — doi:10.1001/archneur.62.5.779. — PMID15883266.
Allegri R.F., Butman J., Arizaga R.L., et al. Economic impact of dementia in developing countries: an evaluation of costs of Alzheimer-type dementia in Argentina (англ.) // Int Psychogeriatr : journal. — 2007. — August (vol. 19, no. 4). — P. 705—718. — doi:10.1017/S1041610206003784. — PMID16870037.
Wimo A., Jonsson L., Winblad B. An estimate of the worldwide prevalence and direct costs of dementia in 2003 (англ.) // Dement Geriatr Cogn Disord : journal. — 2006. — Vol. 21, no. 3. — P. 175—181. — doi:10.1159/000090733. — PMID16401889.
Moore M.J., Zhu C.W., Clipp E.C. Informal costs of dementia care: estimates from the National Longitudinal Caregiver Study (англ.) // J Gerontol B Psychol Sci Soc Sci : journal. — 2001. — July (vol. 56, no. 4). — P. S219—28. — PMID11445614.
Pusey H., Richards D. A systematic review of the effectiveness of psychosocial interventions for carers of people with dementia (англ.) // Aging and Mental Health[англ.] : journal. — 2001. — May (vol. 5, no. 2). — P. 107—119. — PMID11511058.
Garrard P., Maloney L.M., Hodges J.R., Patterson K. The effects of very early Alzheimer's disease on the characteristics of writing by a renowned author (англ.) // Brain[англ.] : journal. — Oxford University Press, 2005. — February (vol. 128, no. Pt 2). — P. 250—260. — doi:10.1093/brain/awh341. — PMID15574466.
Sherman F.T. Did President Reagan have mild cognitive impairment while in office? Living longer with Alzheimer's Disease (англ.) // Geriatrics : journal. — 2004. — September (vol. 59, no. 9). — P. 11, 15. — PMID15461232.
Vaccination:
Hawkes C.A., McLaurin J. Immunotherapy as treatment for Alzheimer's disease (англ.) // Expert Rev Neurother. — 2007. — November (vol. 7, no. 11). — P. 1535—1548. — doi:10.1586/14737175.7.11.1535. — PMID17997702.
Etanercept research:
Tobinick E., Gross H., Weinberger A., Cohen H. TNF-alpha modulation for treatment of Alzheimer's disease: a 6-month pilot study (англ.) // MedGenMed : journal. — 2006. — Vol. 8, no. 2. — P. 25. — PMID16926764. — PMC1785182.
Raha, S., Ghosh, A., Dutta, D., Patel, D. R., & Pahan, K. (2021). Activation of PPARα enhances astroglial uptake and degradation of β-amyloid. Science Signaling, 14(706), eabg4747. PMID34699252doi:10.1126/scisignal.abg4747
Doody R.S., Gavrilova S.I., Sano M., et al. Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study (англ.) // The Lancet : journal. — Elsevier, 2008. — July (vol. 372, no. 9634). — P. 207—215. — doi:10.1016/S0140-6736(08)61074-0. — PMID18640457.
Choi Se Hoon, Kim Young Hye, Hebisch Matthias, Sliwinski Christopher, Lee Seungkyu, d’Avanzo Carla, Chen Hechao, Hooli Basavaraj, Asselin Caroline, Muffat Julien, Klee Justin B., Zhang Can, Wainger Brian J., Peitz Michael, Kovacs Dora M., Woolf Clifford J., Wagner Steven L., Tanzi Rudolph E., Kim Doo Yeon.A three-dimensional human neural cell culture model of Alzheimer’s disease (англ.) // Nature. — 2014. — Vol. 515. — P. 274—278. — ISSN0028-0836. — doi:10.1038/nature13800. Архивировано 29 мая 2016 года.
Donepezil (неопр.). US National Library of Medicine (Medline Plus) (8 января 2007). Дата обращения: 20 марта 2008. Архивировано 25 августа 2011 года.
Galantamine (неопр.). US National Library of Medicine (Medline Plus) (8 января 2007). Дата обращения: 20 марта 2008. Архивировано 25 августа 2011 года.
Rivastigmine (неопр.). US National Library of Medicine (Medline Plus) (8 января 2007). Дата обращения: 20 марта 2008. Архивировано 25 августа 2011 года.
Rivastigmine Transdermal (неопр.). US National Library of Medicine (Medline Plus) (8 января 2007). Дата обращения: 20 марта 2008. Архивировано 25 августа 2011 года.
Memantine (неопр.). US National Library of Medicine (Medline) (4 января 2004). Дата обращения: 22 марта 2008. Архивировано 25 августа 2011 года.
Болезнь Альцгеймера чаще поражает женщин, выяснили учёные. Мозг женщин быстрее накапливает в себе обрывки «белкового мусора», что ускоряет развитие болезни Альцгеймера и проявление её клинических симптомов(рус.). РИА Новости (4 февраля 2019). Дата обращения: 14 апреля 2021. Архивировано 14 апреля 2021 года.
Болезнь Альцгеймера чаще поражает женщин, выяснили учёные. Мозг женщин быстрее накапливает в себе обрывки «белкового мусора», что ускоряет развитие болезни Альцгеймера и проявление её клинических симптомов(рус.). РИА Новости (4 февраля 2019). Дата обращения: 14 апреля 2021. Архивировано 14 апреля 2021 года.
Н. Романов.Болезнь Альцгеймера (неопр.). Все о нейродегенеративных заболеваниях. Деменция.com (10 января 2014). Дата обращения: 31 июля 2015. Архивировано из оригинала 12 августа 2015 года.
Aducanumab : Alzheimer’s Disease : Combined FDA and Biogen Briefing Information for the November 6, 2020 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee : [англ.] : [арх. 7 ноября 2020] / Peripheral and Central Nervous System (PCNS) Drugs Advisory Committee; FDA. — 2020. — 6 November. — 343 p. — NDA/BLA# 761178.
Choi Se Hoon, Kim Young Hye, Hebisch Matthias, Sliwinski Christopher, Lee Seungkyu, d’Avanzo Carla, Chen Hechao, Hooli Basavaraj, Asselin Caroline, Muffat Julien, Klee Justin B., Zhang Can, Wainger Brian J., Peitz Michael, Kovacs Dora M., Woolf Clifford J., Wagner Steven L., Tanzi Rudolph E., Kim Doo Yeon.A three-dimensional human neural cell culture model of Alzheimer’s disease (англ.) // Nature. — 2014. — Vol. 515. — P. 274—278. — ISSN0028-0836. — doi:10.1038/nature13800. Архивировано 29 мая 2016 года.
Donepezil (неопр.). US National Library of Medicine (Medline Plus) (8 января 2007). Дата обращения: 20 марта 2008. Архивировано 25 августа 2011 года.
Galantamine (неопр.). US National Library of Medicine (Medline Plus) (8 января 2007). Дата обращения: 20 марта 2008. Архивировано 25 августа 2011 года.
Rivastigmine (неопр.). US National Library of Medicine (Medline Plus) (8 января 2007). Дата обращения: 20 марта 2008. Архивировано 25 августа 2011 года.
Rivastigmine Transdermal (неопр.). US National Library of Medicine (Medline Plus) (8 января 2007). Дата обращения: 20 марта 2008. Архивировано 25 августа 2011 года.
Memantine (неопр.). US National Library of Medicine (Medline) (4 января 2004). Дата обращения: 22 марта 2008. Архивировано 25 августа 2011 года.
Brookmeyer R., Gray S., Kawas C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset (англ.) // American Journal of Public Health[англ.] : journal. — 1998. — September (vol. 88, no. 9). — P. 1337—1342. — PMID9736873. — PMC1509089.
Tabert M.H., Liu X., Doty R.L., Serby M., Zamora D., Pelton G.H., Marder K., Albers M.W., Stern Y., Devanand D.P. A 10-item smell identification scale related to risk for Alzheimer's disease (англ.) // Annals of Neurology[англ.] : journal. — 2005. — Vol. 58, no. 1. — P. 155—160. — ISSN0364-5134. — doi:10.1002/ana.20533. — PMID15984022.
Mölsä P.K., Marttila R.J., Rinne U.K. Survival and cause of death in Alzheimer's disease and multi-infarct dementia (англ.) // Acta Neurologica Scandinavica[англ.] : journal. — 1986. — August (vol. 74, no. 2). — P. 103—107. — PMID3776457.
Mölsä P.K., Marttila R.J., Rinne U.K. Long-term survival and predictors of mortality in Alzheimer's disease and multi-infarct dementia (англ.) // Acta Neurologica Scandinavica[англ.] : journal. — 1995. — March (vol. 91, no. 3). — P. 159—164. — PMID7793228.
Tiraboschi P., Hansen L.A., Thal L.J., Corey-Bloom J. The importance of neuritic plaques and tangles to the development and evolution of AD (англ.) // Neurology : journal. — Wolters Kluwer[англ.], 2004. — June (vol. 62, no. 11). — P. 1984—1989. — PMID15184601.
Bonin-Guillaume S., Zekry D., Giacobini E., Gold G., Michel J.P. Impact économique de la démence (English: The economical impact of dementia) (фр.) // La Presse médicale[англ.]. — 2005. — Janvier (vol. 34, no 1). — P. 35—41. — ISSN0755-4982. — PMID15685097.
Katzman Robert, Terry Robert D., Bick Katherine L (editors). Alzheimer's disease: senile dementia and related disorders (англ.). — New York: Raven Press[англ.], 1978. — P. 595. — ISBN 0-89004-225-X.
Amaducci L.A., Rocca W.A., Schoenberg B.S. Origin of the distinction between Alzheimer's disease and senile dementia: how history can clarify nosology (англ.) // Neurology : journal. — Wolters Kluwer[англ.], 1986. — November (vol. 36, no. 11). — P. 1497—1499. — PMID3531918.
Di Carlo A., Baldereschi M., Amaducci L., et al. Incidence of dementia, Alzheimer's disease, and vascular dementia in Italy. The ILSA Study (англ.) // Journal of the American Geriatrics Society[англ.] : journal. — 2002. — January (vol. 50, no. 1). — P. 41—8. — PMID12028245.
Andersen K., Launer L.J., Dewey M.E., et al. Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group (англ.) // Neurology : journal. — Wolters Kluwer[англ.], 1999. — December (vol. 53, no. 9). — P. 1992—1997. — PMID10599770.
Preclinical: *Linn R.T., Wolf P.A., Bachman D.L., et al. The 'preclinical phase' of probable Alzheimer's disease. A 13-year prospective study of the Framingham cohort (англ.) // JAMA : journal. — 1995. — May (vol. 52, no. 5). — P. 485—490. — PMID7733843.
Saxton J., Lopez O.L., Ratcliff G., et al. Preclinical Alzheimer disease: neuropsychological test performance 1.5 to 8 years prior to onset (англ.) // Neurology : journal. — Wolters Kluwer[англ.], 2004. — December (vol. 63, no. 12). — P. 2341—2347. — PMID15623697.
Perneczky R., Pohl C., Sorg C., Hartmann J., Komossa K., Alexopoulos P., Wagenpfeil S., Kurz A. Complex activities of daily living in mild cognitive impairment: conceptual and diagnostic issues (англ.) // Age and Ageing[англ.] : journal. — 2006. — Vol. 35, no. 3. — P. 240—245. — doi:10.1093/ageing/afj054. — PMID16513677.
Robert P.H., Berr C., Volteau M., Bertogliati C., Benoit M., Sarazin M., Legrain S., Dubois B. Apathy in patients with mild cognitive impairment and the risk of developing dementia of Alzheimer's disease: a one-year follow-up study (англ.) // Clinical Neurology and Neurosurgery[англ.] : journal. — 2006. — Vol. 108, no. 8. — P. 733—736. — doi:10.1016/j.clineuro.2006.02.003. — PMID16567037.
Carlesimo G.A., Oscar-Berman M. Memory deficits in Alzheimer's patients: a comprehensive review (англ.) // Neuropsychology Review[англ.] : journal. — 1992. — June (vol. 3, no. 2). — P. 119—169. — PMID1300219.
Becker J.T., Overman A.A. [The semantic memory deficit in Alzheimer's disease] (Spanish; Castilian) // Revue neurologique[англ.]. — 2002. — Т. 35, № 8. — С. 777—783. — PMID12402233.
Hodges J.R., Patterson K. Is semantic memory consistently impaired early in the course of Alzheimer's disease? Neuroanatomical and diagnostic implications (англ.) // Neuropsychologia[англ.] : journal. — 1995. — April (vol. 33, no. 4). — P. 441—459. — PMID7617154.
Gold D.P., Reis M.F., Markiewicz D., Andres D. When home caregiving ends: a longitudinal study of outcomes for caregivers of relatives with dementia (англ.) // Journal of the American Geriatrics Society[англ.] : journal. — 1995. — January (vol. 43, no. 1). — P. 10—6. — PMID7806732.
Souren L.E., Franssen E.H., Reisberg B. Contractures and loss of function in patients with Alzheimer's disease (англ.) // Journal of the American Geriatrics Society[англ.] : journal. — 1995. — June (vol. 43, no. 6). — P. 650—655. — PMID7775724.
Berkhout A.M., Cools H.J., van Houwelingen H.C. The relationship between difficulties in feeding oneself and loss of weight in nursing-home patients with dementia (англ.) // Age and Ageing[англ.] : journal. — 1998. — September (vol. 27, no. 5). — P. 637—641. — PMID12675103.
Hardy J., Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer's disease (англ.) // Trends[англ.] : journal. — 1991. — October (vol. 12, no. 10). — P. 383—388. — PMID1763432.
Mudher A., Lovestone S. Alzheimer's disease-do tauists and baptists finally shake hands? (англ.) // Trends[англ.] : journal. — 2002. — January (vol. 25, no. 1). — P. 22—26. — PMID11801334.
Schmitz C., Rutten B.P., Pielen A., et al. Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease (англ.) // The American Journal of Pathology[англ.] : journal. — 2004. — April (vol. 164, no. 4). — P. 1495—1502. — PMID15039236. — PMC1615337.
Goedert M., Spillantini M.G., Crowther R.A. Tau proteins and neurofibrillary degeneration (англ.) // Brain Pathology[англ.]. — 1991. — July (vol. 1, no. 4). — P. 279—286. — PMID1669718.
Bouras C., Hof P.R., Giannakopoulos P., Michel J.P., Morrison J.H. Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a one-year autopsy population from a geriatric hospital (англ.) // Cerebral Cortex[англ.] : journal. — 1994. — Vol. 4, no. 2. — P. 138—150. — PMID8038565.
Hashimoto M., Rockenstein E., Crews L., Masliah E. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases (англ.) // NeuroMolecular Medicine[англ.] : journal. — 2003. — Vol. 4, no. 1—2. — P. 21—36. — doi:10.1385/NMM:4:1-2:21. — PMID14528050.
Priller C., Bauer T., Mitteregger G., Krebs B., Kretzschmar H.A., Herms J. Synapse formation and function is modulated by the amyloid precursor protein (англ.) // Journal of Neuroscience[англ.] : journal. — 2006. — July (vol. 26, no. 27). — P. 7212—7221. — doi:10.1523/JNEUROSCI.1450-06.2006. — PMID16822978.
Campion D., Dumanchin C., Hannequin D., et al. Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum (англ.) // American Journal of Human Genetics[англ.] : journal. — 1999. — September (vol. 65, no. 3). — P. 664—670. — doi:10.1086/302553. — PMID10441572. — PMC1377972.
McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease (англ.) // Neurology : journal. — Wolters Kluwer[англ.], 1984. — July (vol. 34, no. 7). — P. 939—944. — PMID6610841.
Pasquier F. Early diagnosis of dementia: neuropsychology (англ.) // Journal of Neurology[англ.]. — 1999. — January (vol. 246, no. 1). — P. 6—15. — PMID9987708.
Waldemar G., Dubois B., Emre M., et al. Recommendations for the Diagnosis and Management of Alzheimer's Disease and Other Disorders Associated with Dementia: EFNS Guideline (англ.) // European Journal of Neurology[англ.] : journal. — 2007. — January (vol. 14, no. 1). — P. e1—26. — doi:10.1111/j.1468-1331.2006.01605.x. — PMID17222085.
Harvey P.D., Moriarty P.J., Kleinman L., et al. The validation of a caregiver assessment of dementia: the Dementia Severity Scale (англ.) // Alzheimer Disease and Associated Disorders[англ.] : journal. — 2005. — Vol. 19, no. 4. — P. 186—194. — PMID16327345.
Geldmacher D.S., Whitehouse P.J. Differential diagnosis of Alzheimer's disease (англ.) // Neurology. — Wolters Kluwer[англ.], 1997. — May (vol. 48, no. 5 Suppl 6). — P. S2—9. — PMID9153154.
PiB PET:
Kemppainen N.M., Aalto S., Karrasch M., et al. Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease (англ.) // Annals of Neurology[англ.] : journal. — 2008. — January (vol. 63, no. 1). — P. 112—118. — doi:10.1002/ana.21212. — PMID18023012.
Morris M.C., Evans D.A., Schneider J.A., Tangney C.C., Bienias J.L., Aggarwal N.T. Dietary folate and vitamins B-12 and B-6 not associated with incident Alzheimer's disease (англ.) // Journal of Alzheimer's Disease[англ.] : journal. — 2006. — Vol. 9, no. 4. — P. 435—443. — PMID16917153.
Curcumin in diet:
Garcia-Alloza M., Borrelli L.A., Rozkalne A., Hyman B.T., Bacskai B.J. Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model (англ.) // Journal of Neurochemistry[англ.] : journal. — 2007. — Vol. 102, no. 4. — P. 1095—1104. — doi:10.1111/j.1471-4159.2007.04613.x. — PMID17472706.
Patterson C., Feightner J.W., Garcia A., Hsiung G.Y., MacKnight C., Sadovnick A.D. Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease (англ.) // Canadian Medical Association Journal[англ.] : journal. — 2008. — February (vol. 178, no. 5). — P. 548—556. — doi:10.1503/cmaj.070796. — PMID18299540. — PMC2244657.
Reiss A.B., Wirkowski E. Role of HMG-CoA reductase inhibitors in neurological disorders : progress to date (англ.) // Drugs[англ.] : journal. — Adis International, 2007. — Vol. 67, no. 15. — P. 2111—2120. — PMID17927279.
Shcherbatykh I., Carpenter D.O. The role of metals in the etiology of Alzheimer's disease (англ.) // Journal of Alzheimer's Disease[англ.] : journal. — 2007. — May (vol. 11, no. 2). — P. 191—205. — PMID17522444.
Graves A.B., Rosner D., Echeverria D., Mortimer J.A., Larson E.B. Occupational exposures to solvents and aluminium and estimated risk of Alzheimer's disease (англ.) // Occupational and Environmental Medicine[англ.] : journal. — 1998. — September (vol. 55, no. 9). — P. 627—633. — PMID9861186. — PMC1757634.
Stahl S.M. The new cholinesterase inhibitors for Alzheimer's disease, Part 2: illustrating their mechanisms of action (англ.) // The Journal of Clinical Psychiatry[англ.] : journal. — 2000. — Vol. 61, no. 11. — P. 813—814. — PMID11105732.
Raschetti R., Albanese E., Vanacore N., Maggini M. Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials (англ.) // PLOS Medicine[англ.] : journal. — 2007. — Vol. 4, no. 11. — P. e338. — doi:10.1371/journal.pmed.0040338. — PMID18044984.
Raina P., Santaguida P., Ismaila A., et al. Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline (англ.) // Annals of Internal Medicine[англ.] : journal. — 2008. — Vol. 148, no. 5. — P. 379—397. — PMID18316756.
Bottino C.M., Carvalho I.A., Alvarez A.M., et al. Cognitive rehabilitation combined with drug treatment in Alzheimer's disease patients: a pilot study (англ.) // Clinical Rehabilitation[англ.] : journal. — 2005. — Vol. 19, no. 8. — P. 861—869. — doi:10.1191/0269215505cr911oa. — PMID16323385.
Doody R.S., Stevens J.C., Beck C., et al. Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology (англ.) // Neurology : journal. — Wolters Kluwer[англ.], 2001. — Vol. 56, no. 9. — P. 1154—1166. — PMID11342679.
Camberg L., Woods P., Ooi W.L., et al. Evaluation of Simulated Presence: a personalised approach to enhance well-being in persons with Alzheimer's disease (англ.) // Journal of the American Geriatrics Society[англ.] : journal. — 1999. — Vol. 47, no. 4. — P. 446—452. — PMID10203120.
Bowen J.D., Malter A.D., Sheppard L., et al. Predictors of mortality in patients diagnosed with probable Alzheimer's disease (англ.) // Neurology : journal. — Wolters Kluwer[англ.], 1996. — August (vol. 47, no. 2). — P. 433—439. — PMID8757016.
Larson E.B., Shadlen M.F., Wang L., et al. Survival after initial diagnosis of Alzheimer disease (англ.) // Annals of Internal Medicine[англ.] : journal. — 2004. — April (vol. 140, no. 7). — P. 501—509. — PMID15068977.
Jagger C., Clarke M., Stone A. Predictors of survival with Alzheimer's disease: a community-based study (англ.) // Psychological Medicine[англ.] : journal. — 1995. — January (vol. 25, no. 1). — P. 171—177. — PMID7792352.
Pusey H., Richards D. A systematic review of the effectiveness of psychosocial interventions for carers of people with dementia (англ.) // Aging and Mental Health[англ.] : journal. — 2001. — May (vol. 5, no. 2). — P. 107—119. — PMID11511058.
Garrard P., Maloney L.M., Hodges J.R., Patterson K. The effects of very early Alzheimer's disease on the characteristics of writing by a renowned author (англ.) // Brain[англ.] : journal. — Oxford University Press, 2005. — February (vol. 128, no. Pt 2). — P. 250—260. — doi:10.1093/brain/awh341. — PMID15574466.
Bonin-Guillaume S., Zekry D., Giacobini E., Gold G., Michel J.P. Impact économique de la démence (English: The economical impact of dementia) (фр.) // La Presse médicale[англ.]. — 2005. — Janvier (vol. 34, no 1). — P. 35—41. — ISSN0755-4982. — PMID15685097.
Musiek Erik S, Holtzman David M. Three dimensions of the amyloid hypothesis: time, space and 'wingmen' // Nature Neuroscience. — 2015. — Vol. 18. — P. 800—806. — ISSN1097-6256. — doi:10.1038/nn.4018. — PMID26007213.
Choi Se Hoon, Kim Young Hye, Hebisch Matthias, Sliwinski Christopher, Lee Seungkyu, d’Avanzo Carla, Chen Hechao, Hooli Basavaraj, Asselin Caroline, Muffat Julien, Klee Justin B., Zhang Can, Wainger Brian J., Peitz Michael, Kovacs Dora M., Woolf Clifford J., Wagner Steven L., Tanzi Rudolph E., Kim Doo Yeon.A three-dimensional human neural cell culture model of Alzheimer’s disease (англ.) // Nature. — 2014. — Vol. 515. — P. 274—278. — ISSN0028-0836. — doi:10.1038/nature13800. Архивировано 29 мая 2016 года.
